A landscape of sequence variants in 51 commercial antibody therapeutics.

Xu G, Wu G, Cui C, Wei S, Duan M, Cui Y, Mei YT, Yu C, Wang L

DOI: 10.1093/abt/tbag048
Published: 2026 Oct
Container: Antibody therapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/abt/tbag048,
  title = {A landscape of sequence variants in 51 commercial antibody therapeutics.},
  author = {Xu G and Wu G and Cui C and Wei S and Duan M and Cui Y and Mei YT and Yu C and Wang L},
  year = {2026},
  journal = {Antibody therapeutics},
  doi = {10.1093/abt/tbag048},
  url = {https://doi.org/10.1093/abt/tbag048}
}

RIS

TY  - JOUR
TI  - A landscape of sequence variants in 51 commercial antibody therapeutics.
AU  - Xu G
AU  - Wu G
AU  - Cui C
AU  - Wei S
AU  - Duan M
AU  - Cui Y
AU  - Mei YT
AU  - Yu C
AU  - Wang L
PY  - 2026
JO  - Antibody therapeutics
DO  - 10.1093/abt/tbag048
UR  - https://doi.org/10.1093/abt/tbag048
ER  -

APA

G, X., G, W., C, C., S, W., M, D., Y, C., YT, M., C, Y., & L, W. (2026). A landscape of sequence variants in 51 commercial antibody therapeutics.. Antibody therapeutics. https://doi.org/10.1093/abt/tbag048

Source records

pubmed · retrieved 2026-11-10T09:52:06.512Z